Athens Medical C.S.A. (IATR.AT)
EUR 1.55
(0.0%)
EUR 1.55
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 26.16 Million | 124 Thousand | 15.74 Million | 40.2 Million | 31.49 Million | 20.02 Million |
| Net Income | 8.08 Million | 10.71 Million | 15.33 Million | 5.5 Million | 10.77 Million | 9.4 Million |
| Depreciation & Amortization | 14.92 Million | 13.78 Million | 12.89 Million | 12.33 Million | 11.12 Million | 7.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.98 Million | -31.18 Million | -18.67 Million | 20.68 Million | 7.01 Million | 3.01 Million |
| Other non-cash items | 48.97 Million | 6.8 Million | 6.19 Million | 1.68 Million | 2.58 Million | -359 Thousand |
| Investing Cash Flow | -23.63 Million | -15.78 Million | -6.95 Million | -7.11 Million | -15.41 Million | -7.86 Million |
| Investments in PPE | -22.35 Million | -15.87 Million | -11.28 Million | -7.07 Million | -16.26 Million | -7.96 Million |
| Acquisitions | 18 Thousand | 52 Thousand | 435 Thousand | 14 Thousand | 846 Thousand | 76 Thousand |
| Investment purchases | -1.3 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.25 Million | 42 Thousand | 3.89 Million | -51 Thousand | 5000.00 | 98 Thousand |
| Financing Cash Flow | 2.75 Million | -19.64 Million | -6.06 Million | 8.66 Million | -13.16 Million | -10.8 Million |
| Debt repayment | -11.61 Million | -18.53 Million | -10.54 Million | -13.99 Million | -10.36 Million | -10.64 Million |
| Dividends payments | -61 Thousand | - | -81 Thousand | -141 Thousand | -39 Thousand | -81 Thousand |
| Common Stock Repurchased | -2.59 Million | -6.04 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.59 Million | 4.93 Million | 4.56 Million | 22.8 Million | -2.76 Million | -78 Thousand |
| Accounts receivables | -40.04 Million | -26.18 Million | -3.07 Million | -10.82 Million | 11.63 Million | 5.43 Million |
| Accounts payables | 31.99 Million | -4.99 Million | -15.49 Million | 10.82 Million | -11.63 Million | - |
| Inventory | 62 Thousand | -4000.00 | -113 Thousand | -1.02 Million | -932 Thousand | -398 Thousand |
| Other working capital | 31.99 Million | -4.99 Million | -15.49 Million | 21.71 Million | 7.94 Million | 3.41 Million |
| Cash at beginning of period | 23.29 Million | 51.98 Million | 49.25 Million | 7.5 Million | 4.58 Million | 3.22 Million |
| Cash at end of period | 29.32 Million | 16.68 Million | 51.98 Million | 49.25 Million | 7.5 Million | 4.58 Million |
| Capital Expenditure | -22.35 Million | -15.87 Million | -11.28 Million | -7.07 Million | -16.26 Million | -7.96 Million |
| Effect of forex changes on cash | - | - | - | - | - | 1000.00 |
| Net cash flow / Change in cash | 6.02 Million | -35.3 Million | 2.72 Million | 41.75 Million | 2.91 Million | 1.35 Million |
| Free Cash Flow | 3.81 Million | -15.75 Million | 4.46 Million | 33.12 Million | 15.22 Million | 12.06 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.83 Million | 3.83 Million | 22 Thousand | 8.08 Million | 8.06 Million | 4.03 Million |
| Depreciation & Amortization | 4.11 Million | 4.11 Million | 7.7 Million | 14.92 Million | 7.22 Million | 3.47 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 5.83 Million | 5.83 Million | 9.32 Million | -7.98 Million | -17.3 Million | -8.65 Million |
| Other non-cash items | 2.91 Million | 2.91 Million | 8.82 Million | 48.97 Million | 40.15 Million | 4.32 Million |
| Investing Cash Flow | -8.27 Million | -8.27 Million | -13.27 Million | -23.63 Million | -10.36 Million | -5.17 Million |
| Investments in PPE | -8.03 Million | -8.03 Million | -11.96 Million | -22.35 Million | -10.38 Million | -5.19 Million |
| Acquisitions | 16 Thousand | - | 1000.00 | 18 Thousand | 17 Thousand | - |
| Investment purchases | -500 Thousand | - | -1.3 Million | -1.3 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -239.5 Thousand | -239.5 Thousand | -1000.00 | - | 21 Thousand | 21 Thousand |
| Financing Cash Flow | -6.27 Million | -6.27 Million | -891 Thousand | 2.75 Million | 3.64 Million | 1.82 Million |
| Debt repayment | -8.5 Million | - | -5.13 Million | -11.61 Million | -6.47 Million | - |
| Dividends payments | - | - | - | -61 Thousand | -61 Thousand | -30.5 Thousand |
| Common Stock Repurchased | - | - | - | -2.59 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6.27 Million | -6.27 Million | -2.59 Million | -2.59 Million | 1.85 Million | 1.85 Million |
| Accounts receivables | -2.41 Million | -2.41 Million | -3.03 Million | -40.04 Million | -37.01 Million | -18.5 Million |
| Accounts payables | 16.28 Million | - | 12.79 Million | 31.99 Million | 19.19 Million | - |
| Inventory | 107.5 Thousand | 107.5 Thousand | -442 Thousand | 62 Thousand | 504 Thousand | 252 Thousand |
| Other working capital | 8.14 Million | 8.14 Million | - | - | 9.59 Million | 9.59 Million |
| Cash at beginning of period | 29.32 Million | - | 24 Million | 23.29 Million | 23.29 Million | - |
| Cash at end of period | 34.28 Million | 2.14 Million | 29.32 Million | 29.32 Million | 24 Million | -172.5 Thousand |
| Capital Expenditure | -8.03 Million | -8.03 Million | -11.96 Million | -22.35 Million | -10.38 Million | -5.19 Million |
| Effect of forex changes on cash | - | - | - | - | 1.05 Million | - |
| Net cash flow / Change in cash | 4.96 Million | 2.14 Million | 5.31 Million | 6.02 Million | 710 Thousand | -172.5 Thousand |
| Free Cash Flow | 8.66 Million | 8.66 Million | 7.82 Million | 3.81 Million | -4.01 Million | -2.01 Million |
SWID
NRDE
BLPFF
MGL
EOF
0217